Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide add-on in focal epilepsy
NCT00165828Phase 4Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2005
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zonisamide in focal epilepsy, sponsored by Eisai Co., Ltd.. Started May 2005; status: terminated.
02
Drugs
zonisamide
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00165828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165828.